Crawford Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.46M | Sell |
9,199
-454
| -5% | -$460K | 0.14% | 118 |
|
|
2025
Q4 | $10.4M | Buy |
9,653
+401
| +4% | +$383K | 0.17% | 105 |
|
|
2025
Q3 | $7.06M | Sell |
9,252
-170
| -2% | -$127K | 0.12% | 133 |
|
|
2025
Q2 | $7.34M | Buy |
9,422
+874
| +10% | +$679K | 0.13% | 125 |
|
|
2025
Q1 | $7.06M | Buy |
8,548
+348
| +4% | +$290K | 0.13% | 135 |
|
|
2024
Q4 | $6.33M | Buy |
8,200
+152
| +2% | +$126K | 0.11% | 139 |
|
|
2024
Q3 | $7.13M | Sell |
8,048
-128
| -2% | -$115K | 0.12% | 130 |
|
|
2024
Q2 | $7.4M | Buy |
8,176
+377
| +5% | +$302K | 0.14% | 114 |
|
|
2024
Q1 | $6.07M | Sell |
7,799
-540
| -6% | -$384K | 0.11% | 123 |
|
|
2023
Q4 | $4.86M | Sell |
8,339
-2
| -0% | -$1.17K | 0.1% | 135 |
|
|
2023
Q3 | $4.48M | Sell |
8,341
-231
| -3% | -$119K | 0.1% | 129 |
|
|
2023
Q2 | $4.02M | Buy |
8,572
+923
| +12% | +$387K | 0.08% | 135 |
|
|
2023
Q1 | $2.63M | Buy |
7,649
+202
| +3% | +$68.1K | 0.06% | 152 |
|
|
2022
Q4 | $2.72M | Sell |
7,447
-116
| -2% | -$41.1K | 0.06% | 150 |
|
|
2022
Q3 | $2.44M | Sell |
7,563
-522
| -6% | -$165K | 0.06% | 154 |
|
|
2022
Q2 | $2.62M | Sell |
8,085
-217
| -3% | -$65.1K | 0.06% | 157 |
|
|
2022
Q1 | $2.38M | Sell |
8,302
-704
| -8% | -$181K | 0.05% | 167 |
|
|
2021
Q4 | $2.49M | Sell |
9,006
-174
| -2% | -$44.1K | 0.05% | 168 |
|
|
2021
Q3 | $2.12M | Sell |
9,180
-310
| -3% | -$76.5K | 0.04% | 170 |
|
|
2021
Q2 | $2.18M | Sell |
9,490
-91
| -0.9% | -$18.3K | 0.04% | 168 |
|
|
2021
Q1 | $1.79M | Sell |
9,581
-94
| -1% | -$18.4K | 0.04% | 169 |
|
|
2020
Q4 | $1.63M | Buy |
9,675
+480
| +5% | +$71.7K | 0.04% | 167 |
|
|
2020
Q3 | $1.36M | Sell |
9,195
-47
| -0.5% | -$7.27K | 0.04% | 165 |
|
|
2020
Q2 | $1.52M | Sell |
9,242
-279
| -3% | -$42.8K | 0.04% | 158 |
|
|
2020
Q1 | $1.32M | Sell |
9,521
-3,349
| -26% | -$460K | 0.04% | 158 |
|
|
2019
Q4 | $1.69M | Buy |
12,870
+1,043
| +9% | +$121K | 0.04% | 162 |
|
|
2019
Q3 | $1.32M | Buy |
11,827
+465
| +4% | +$51.8K | 0.04% | 171 |
|
|
2019
Q2 | $1.26M | Sell |
11,362
-620
| -5% | -$73K | 0.04% | 171 |
|
|
2019
Q1 | $1.55M | Buy |
11,982
+110
| +0.9% | +$13.4K | 0.05% | 158 |
|
|
2018
Q4 | $1.37M | Buy |
11,872
+8
| +0.1% | +$894 | 0.05% | 151 |
|
|
2018
Q3 | $1.27M | Hold |
11,864
| – | – | 0.04% | 158 |
|
|
2018
Q2 | $1.01M | Hold |
11,864
| – | – | 0.03% | 166 |
|
|
2018
Q1 | $918K | Sell |
11,864
-411
| -3% | -$33.1K | 0.03% | 170 |
|
|
2017
Q4 | $1.04M | Sell |
12,275
-585
| -5% | -$49.8K | 0.03% | 166 |
|
|
2017
Q3 | $1.1M | Buy |
12,860
+110
| +0.9% | +$9.02K | 0.04% | 159 |
|
|
2017
Q2 | $1.05M | Sell |
12,750
-1,000
| -7% | -$81.6K | 0.04% | 155 |
|
|
2017
Q1 | $1.16M | Buy |
13,750
+156
| +1% | +$12.5K | 0.04% | 153 |
|
|
2016
Q4 | $1M | Sell |
13,594
-55,854
| -80% | -$4.16M | 0.04% | 164 |
|
|
2016
Q3 | $5.57M | Buy |
69,448
+52,750
| +316% | +$4.22M | 0.2% | 75 |
|
|
2016
Q2 | $1.31M | Sell |
16,698
-51
| -0.3% | -$3.84K | 0.05% | 142 |
|
|
2016
Q1 | $1.21M | Sell |
16,749
-2,802
| -14% | -$212K | 0.05% | 142 |
|
|
2015
Q4 | $1.65M | Sell |
19,551
-3,650
| -16% | -$303K | 0.07% | 113 |
|
|
2015
Q3 | $1.94M | Sell |
23,201
-16,163
| -41% | -$1.36M | 0.08% | 95 |
|
|
2015
Q2 | $3.29M | Sell |
39,364
-847,955
| -96% | -$64.6M | 0.12% | 83 |
|
|
2015
Q1 | $64.5M | Sell |
887,319
-177,018
| -17% | -$12.6M | 2.33% | 27 |
|
|
2014
Q4 | $73.4M | Sell |
1,064,337
-99,987
| -9% | -$6.75M | 2.59% | 14 |
|
|
2014
Q3 | $75.5M | Buy |
1,164,324
+5,025
| +0.4% | +$318K | 2.72% | 10 |
|
|
2014
Q2 | $72.1M | Sell |
1,159,299
-44,311
| -4% | -$2.64M | 2.55% | 16 |
|
|
2014
Q1 | $70.8M | Sell |
1,203,610
-14,418
| -1% | -$805K | 2.57% | 18 |
|
|
2013
Q4 | $62.1M | Buy |
1,218,028
+18,183
| +2% | +$911K | 2.28% | 28 |
|
|
2013
Q3 | $60.4M | Buy |
1,199,845
+24,217
| +2% | +$1.27M | 2.39% | 27 |
|
|
2013
Q2 | $57.7M | Buy |
+1,175,628
| New | +$64M | 2.39% | 28 |
|
Other funds holding LLY
VCM
VPM
Crawford Investment Counsel's LLY Position: Q1 2026 in Review
Crawford Investment Counsel reduced its Eli Lilly (LLY) stake by 4.7% in Q1 2026, selling an estimated $460K and leaving 9,199 shares worth $8.46M. The position accounts for 0.14% of the portfolio, ranked #118.
Crawford Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $75.5M in Q3 2014. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Crawford Investment Counsel held 9,199 shares of Eli Lilly worth $8.46M as of Q1 2026.
- Crawford Investment Counsel sold 454 Eli Lilly shares in Q1 2026, an estimated $460K.
- Eli Lilly made up 0.14% of Crawford Investment Counsel's portfolio in Q1 2026, its #118 holding.
- Crawford Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Crawford Investment Counsel's Eli Lilly position peaked at $75.5M in Q3 2014.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.